EQL Pharma AB (7JK) Stock Overview

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.

7JK Stock Information

Symbol

7JK

Address

Stortorget 1Lund, 222 23Sweden

Founded

Trading hours

Website

https://www.eqlpharma.com

Country

🇸🇪 Sweden

Phone Number

46 46 12 01 70

EQL Pharma AB (7JK) Price Chart

EQL Pharma AB Overview: Key Details and Summary

Stock data	2023	Change
Price	$5.41	N/A
Market Cap	$157.37M	N/A
Shares Outstanding	29.06M	0.00%
Employees	18.00	N/A
Shareholder Equity	154.75M	25.18%

Valuation	2023	Change
P/E Ratio	5.21	N/A
P/S Ratio	6.19	N/A
P/B Ratio	1.02	N/A

Growth	2023	Change
Return on Equity	0.0196	N/A

Earnings	2023	Change
Revenue	$25.44M	N/A
Earnings	$3.03M	N/A
EPS	1.04	N/A
Earnings Yield	0.1921	N/A
Gross Margin	0.4457	N/A
Operating Margin	0.1582	N/A
Net income margin	0.119	N/A

Financial Strength	2023	Change
Total Assets	$27.97M	N/A
Total Debt	$6.52M	N/A
Cash on Hand	$4.35M	N/A
Debt to Equity	0.0828	-8.45%
Cash to Debt	0.6669	23.18%
Current Ratio	$1.44	15.35%